Notice 30 Apr 2025 debarment, compliance, education, regulations, fcc, e-rate program

📜Notice of Suspension and Proposed Debarment in E-Rate Program

The Enforcement Bureau (the "Bureau") gives notice of the suspension of Susan Klein from the schools and libraries universal service support mechanism (or "E-Rate Program") and all universal service support mechanisms. Additionally, the Bureau gives notice that debarment proceedings are commencing against Ms. Klein. Ms. Klein, or any person who has an existing contract with or intends to contract with Ms. Klein to provide or receive services in matters arising out of activities associated with or related to the schools and libraries support, may respond by filing an opposition request, supported by documentation.

Learn More
Notice 29 Apr 2025 debarment, e-rate, telecommunications, fcc, compliance, education, suspension

🚫Notice of Suspension and Debarment Proceedings in E-Rate Program

The Enforcement Bureau (the "Bureau") gives notice of the suspension of Moshe Schwartz from the schools and libraries universal service support mechanism (or "E-Rate Program") and all universal service support mechanisms. Additionally, the Bureau gives notice that debarment proceedings are commencing against Mr. Schwartz. Mr. Schwartz, or any person who has an existing contract with or intends to contract with Mr. Schwartz to provide or receive services in matters arising out of activities associated with or related to the schools and libraries support, may respond by filing an opposition request, supported by documentation.

Learn More
Notice 29 Apr 2025 debarment, e-rate, telecommunications, fcc, compliance, federal regulations

🚫FCC Notice

The Enforcement Bureau (the "Bureau") gives notice of the suspension of Aron Melber from the schools and libraries universal service support mechanism (or "E-Rate Program") and all universal service support mechanisms. Additionally, the Bureau gives notice that debarment proceedings are commencing against Mr. Melber. Mr. Melber, or any person who has an existing contract with or intends to contract with Mr. Melber to provide or receive services in matters arising out of activities associated with or related to the schools and libraries support, may respond by filing an opposition request, supported by documentation.

Learn More
Notice 29 Apr 2025 debarment, telecommunications, fcc, compliance, e-rate program

⚖️FCC Notice of Suspension and Proposed Debarment of Ben Klein

The Enforcement Bureau (the "Bureau") gives notice of the suspension of Ben Klein from the schools and libraries universal service support mechanism (or "E-Rate Program") and all universal service support mechanisms. Additionally, the Bureau gives notice that debarment proceedings are commencing against Mr. Klein. Mr. Klein, or any person who has an existing contract with or intends to contract with Mr. Klein to provide or receive services in matters arising out of activities associated with or related to the schools and libraries support, may respond by filing an opposition request, supported by documentation.

Learn More
Notice 14 Mar 2025 regulatory compliance, health care, fda, debarment, drug applications

⚖️FDA Denies Hearing and Issues Permanent Debarment for Garmendia

The Food and Drug Administration (FDA or Agency) is denying a request for a hearing submitted by Bernardo Garmendia, also known as Bernardo Germendia, (Garmendia) and is issuing an order under the Federal Food, Drug, and Cosmetic Act (FD&C Act) permanently debarring Garmendia from providing services in any capacity to a person that has an approved or pending drug product application. FDA bases this order on a finding that Garmendia was convicted of a felony under Federal law for conduct relating to the development or approval, including the process for development or approval, of any drug product under the FD&C Act. FDA provided notice to Garmendia of the proposed debarment and an opportunity to request a hearing within the timeframe prescribed by regulation. Garmendia submitted a request for hearing but failed to file with the Agency information and analyses sufficient to create a basis for a hearing.

Learn More
Notice 13 Mar 2025 compliance, fda, debarment, pharmaceutical, drug regulation, importation, legal

🚫FDA Debars Alnashir Punjani for 5 Years

The Food and Drug Administration (FDA or the Agency) is issuing an order under the Federal Food, Drug, and Cosmetic Act (FD&C Act) debarring Alnashir Alibhai Punjani for a period of 5 years from importing or offering for import any drug into the United States. FDA bases this order on a finding that Mr. Punjani was convicted of one felony count under Federal law for conspiracy to deliver and introduce unapproved drugs. The factual basis supporting Mr. Punjani's conviction, as described below, is conduct relating to the importation into the United States of a drug or controlled substance. Mr. Punjani was given notice of the proposed debarment and was given an opportunity to request a hearing to show why he should not be debarred. As of November 10, 2024 (30 days after receipt of the notice), Mr. Punjani had not responded. Mr. Punjani's failure to respond and request a hearing constitutes a waiver of his right to a hearing concerning this matter.

Learn More
Notice 13 Mar 2025 compliance, fda, debarment, health, sanctions, drug regulation, legal

⚖️Implications of John Kosolcharoen's FDA Debarment Order

The Food and Drug Administration (FDA) is issuing an order under the Federal Food, Drug, and Cosmetic Act (FD&C Act) permanently debarring John Warrington Kosolcharoen from providing services in any capacity to a person that has an approved or pending drug product application including, but not limited to, a biologics license application (BLA). FDA bases this order on a finding that Mr. Kosolcharoen was convicted of a felony under Federal law for conduct that relates to the regulation of a drug product under the FD&C Act. Mr. Kosolcharoen was given notice of the proposed debarment and an opportunity to request a hearing within the timeframe prescribed by regulation. As of December 26, 2024 (30 days after receipt of the notice), Mr. Kosolcharoen has not responded. Mr. Kosolcharoen's failure to respond and request a hearing constitutes a waiver of Mr. Kosolcharoen's right to a hearing concerning this matter.

Learn More
Notice 13 Mar 2025 compliance, regulation, fda, debarment, pharmaceutical, drug importation

🚫FDA Issues 10-Year Debarment Order Against Harpreet Singh

The Food and Drug Administration (FDA) is issuing an order under the Federal Food, Drug, and Cosmetic Act (FD&C Act) debarring Harpreet Singh for a period of 10 years from importing or offering for import any drug into the United States. FDA bases this order on a finding Mr. Singh was convicted of multiple felony offenses, which serve as the basis for this debarment, that are conspiracy to possess with intent to distribute cathinone, tapentadol, tramadol, and carisoprodol; one felony count under Federal law for fraudulent importation and transportation of goods; one felony count under Federal law for conspiracy to launder money; and one felony count under Federal law for conspiracy to obstruct justice. The factual basis supporting Mr. Singh's conviction, as described below, is conduct relating to the importation into the United States of a drug or controlled substance. Mr. Singh was given notice of the proposed debarment and was given an opportunity to request a hearing to show why he should not be debarred. As of November 20, 2024 (30 days after receipt of the notice), Mr. Singh had not responded. Mr. Singh's failure to respond and request a hearing constitutes a waiver of his right to a hearing concerning this matter.

Learn More
Notice 13 Mar 2025 compliance, regulation, fda, debarment, pharmaceutical, drug importation, legal

⚖️FDA Debarment Order Against Jonathan Corbett Cosie

The Food and Drug Administration (FDA) is issuing an order under the Federal Food, Drug, and Cosmetic Act (FD&C Act) debarring Jonathan Corbett Cosie for a period of 10 years from importing or offering for import any drug into the United States. FDA bases this order on a finding that Mr. Cosie was convicted of two felony counts under Federal law for introducing misbranded drugs into interstate commerce with the intent to defraud and mislead. The factual basis supporting Mr. Cosie's conviction, as described below, is conduct relating to the importation into the United States of a drug or controlled substance. Mr. Cosie was given notice of the proposed debarment and was given an opportunity to request a hearing to show why he should not be debarred. As of January 6, 2025 (30 days after receipt of the notice), Mr. Cosie had not responded. Mr. Cosie's failure to respond and request a hearing constitutes a waiver of his right to a hearing concerning this matter.

Learn More
Regulatory, Compliance 8 Jan 2025 regulation, business compliance, fda, debarment, health

❌FDA Withdraws Notice on Yong Sheng Jiao's Debarment Order

The Food and Drug Administration (FDA) is issuing this notice to withdraw the December 5, 2024, Federal Register notice entitled "Yong Sheng Jiao; Denial of Hearing; Final Debarment Order" because the document provided the incorrect bases for debarment and omitted edited language. A corrected notice document is published elsewhere in this Federal Register.

Learn More